- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
BioForce Nanosciences Holdings, Inc. (OTC BB: BFNH), a producer of integrated biological and mechanical systems for life science researchers at the micro and nano scales, today announced that has added a new product to its increasing portfolio of market offerings, the Nano eNabler CB™, a molecular printer specially adapted to serve the needs of cellular biology researchers. The tool is similar to its flagship machine, the Nano eNabler™ molecular printer which allows researchers to print tiny domains of biological materials on surfaces with nanometer special precision.
Kerry Frey, President and Chief Executive Officer of BioForce Nanosciences, said, "This extension of our product line reinforces the value of our flagship product, the Nano eNabler. The customized Nano eNabler CB is designed to answer the needs of the cell biology market, for example, in stem cell or cancer research."
Michael Lynch, Product Manager of the Company, said," Last year was incredibly productive and useful in helping the Company define more clearly the needs of our customers. The Nano eNabler CB is the first in a line of new offerings we will introduce to the research market in the next few weeks. It is the result of our close collaborations with our user base and our customer-focused business philosophy. Listening to our users and providing solutions to their problems will keep us on track in the rapidly evolving bio-nanotechnology field and allow us to retain a leadership position as the industry matures."
About BioForce Nanosciences Holdings, Inc.
BioForce Nanosciences creates products and solutions for the life sciences by integrating biological and mechanical systems at the micro and nano scales. BioForce’s flagship product, the Nano eNabler™ molecular printer, gives the Company and its customers a platform for development and discovery by printing tiny domains of biological materials on surfaces with nanometer special precision. BioForce technology is being used in areas such as biosensor functionalization; pattering and cell adhesion; and the printing of proteins to guide neural cell growth. For more information, visit www.bioforcenano.com or call 515-233-8333.
This news release contains forward-looking information that may be affected by certain risks and uncertainties, including those risks and uncertainties described in BioForce Nanosciences' most recent filings with the Securities and Exchange Commission. BioForce Nanosciences' actual results could differ materially from such forward-looking statements. BioForce assumes no duty to update these statements at any future date.
For more information, please click here
BioForce Nanosciences Holdings, Inc.
Gregory D. Brown
Chief Financial Officer
515-233-8333 ext# 118
Porter, LeVay & Rose, Inc.
Marlon Nurse, VP – Investor Relations
or Jeffrey Myhre, VP – Editorial
Copyright © Business Wire 2008If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Soft decoupling of organic molecules on metal June 23rd, 2016
Scientists engineer tunable DNA for electronics applications June 21st, 2016
FEI Launches Helios G4 DualBeam Series for Materials Science: The Helios G4 DualBeam Series features new capabilities to enable scientists and engineers to answer the most demanding and challenging scientific questions June 27th, 2016